Google Scholar | Citations: 1937 | h-index: 18 | i10-index: 52
Indiscriminate use of antibiotics in pediatric respiratory infections: clinical risks and bacterial resistance
PDF (Portuguese (Brazil))

Keywords

Antibiotics
Infections
Pediatrics

How to Cite

Indiscriminate use of antibiotics in pediatric respiratory infections: clinical risks and bacterial resistance. (2025). Revista Eletrônica Acervo Científico, 25, e22593. https://doi.org/10.25248/reac.e22593.2025

Copyright © | All rights reserved.

The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.

Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.

Total reproduction
It is expressly prohibited and must be authorized by the journal.

Abstract

Objective: Analyze the main factors associated with the inappropriate use of antibiotics in pediatric respiratory infections. Literature review: Acute respiratory infections are among the most prevalent childhood conditions and account for a large proportion of antimicrobial prescriptions, despite most having a viral origin. The difficulty in rapidly distinguishing viral from bacterial infections favors the empirical use of antibiotics, contributing to bacterial resistance and alterations in the infant microbiota. Immunological immaturity, especially in the early years of life, increases vulnerability to infections and reinforces preventive prescribing practices. In addition to biological aspects, behavioral factors influence decision-making, such as parental expectations for antibiotic prescriptions and the persistent culture of self-medication in various contexts. Institutional guidelines and programs have emphasized the importance of rational antimicrobial use, highlighting clinical protocols, epidemiological surveillance, and continuing education for healthcare professionals. Final considerations: Antimicrobial resistance in pediatrics represents a multifactorial challenge that requires coordinated actions. Evidence-based strategies, combined with the awareness of professionals and caregivers, are essential to reduce inappropriate prescriptions, promote responsible antibiotic use, and preserve their efficacy for future generations.

PDF (Portuguese (Brazil))

References

ANVISA. AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA. Diretriz Nacional para Implantação de Programa de Gerenciamento de Antimicrobianos em Serviços de Neonatologia e Pediatria. Brasília: ANVISA, 2025.

ANNAMALAY A, et al. Viral-bacterial interactions in childhood respiratory tract infections. In: Viral Infections in Children, Volume I. Cham: Springer International Publishing, 2017; 193–214.

ARKWRIGHT PD, et al. Recently identified factors predisposing children to infectious diseases. Current Opinion in Infectious Diseases, 2008; 21(3): 217–222.

DIAZ-DIAZ A, et al. Interações virais bacterianas em crianças: Impacto nos desfechos clínicos. The Pediatric Infectious Disease Journal, 2019; 38(6): 14–19.

HESTON SM, et al. Understanding the influence of the microbiome on childhood infections. Expert Review of Anti-Infective Therapy, 2024; 22(7): 529–545.

KALASIKAM M, et al. Antibiotic overuse in a contemporary cohort of children hospitalized with influenza, RSV, or SARS-CoV-2: a retrospective cohort study, BMC Pediatrics, 2025; 25: 759.

KIM K, et al. Global Trends in the Proportion of Macrolide-Resistant Mycoplasma pneumoniae Infections: A Systematic Review and Meta-analysis. JAMA Network Open, 2022; 5(7): 2220949.

KISSLER SM, et al. Impact of Respiratory Infection and Chronic Comorbidities on Early Pediatric Antibiotic Dispensing in the United States. Clinical Infectious Diseases, 2023; 76(3): 382–388.

LEE R, et al. Impact of an antimicrobial stewardship programme on antibiotic utilization and resistance burden in patients with acute leukaemia: an 11-year longitudinal cohort study using interrupted time-series analysis. Journal of Antimicrobial Chemotherapy, 2024; 79(8): 1998–2007.

NICE. NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Antimicrobial Stewardship: Systems and Processes for Effective Antimicrobial Medicine Use (NG15). London: NICE, 2015.

NICE. NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE. Antimicrobial Stewardship: Changing Risk-Related Behaviours in the General Population (NG63). London: NICE, 2017.

NICULESCU AG, et al. From Microbial Ecology to Clinical Challenges: The Respiratory Microbiome's Role in Antibiotic Resistance. Pathogens, 2025; 14(4): 355.

OMS. ORGANIZAÇÃO MUNDIAL DA SAÚDE. WHO Policy Guidance on Integrated Antimicrobial Stewardship Activities. Geneva: World Health Organization, 2021.

PRINCIPI N, et al. Short-term antibiotic therapy for the most common bacterial respiratory infections in infants and children. Frontiers in Pharmacology, 2023; 14: 1174146.

PURLING GKP, et al. Immediate versus Delayed versus No Antibiotics for Respiratory Infections. Cochrane Database of Systematic Reviews, 2023; 10: 4417.

RAMOS ACGS, et al. Perfil microbiológico e de resistência bacteriana em uma unidade de terapia intensiva pediátrica: importância do gerenciamento de antimicrobianos. Revista Eletrônica Acervo Saúde, 2025; 25(5): 20135.

SHAMIM MA, et al. Parents' expectation of antibiotic prescriptions for respiratory infections in children: a systematic review and meta-analysis. Therapeutic Advances in Infectious Disease, 2023; 10: 20499361231 169429.

VAUGHN VM, et al. The association of antibiotic stewardship with fluoroquinolone prescribing in Michigan hospitals: a multi-hospital cohort study. Clinical Infectious Diseases, 2019; 69(8): 1269–1277.

WERAGAMA K, et al. Paediatric Antimicrobial Stewardship for Respiratory Infections in the Emergency Setting: A Systematic Review. Antibiotics, 2021; 10(11): 1366.

YANG L, et al. Global epidemiology of asymptomatic colonisation of methicillin-resistant Staphylococcus aureus in the upper respiratory tract of young children: a systematic review and meta-analysis. Archives of Disease in Childhood, 2024; 109: 267–274.